{
  "id": 204820,
  "name": "FOUNDATION MEDICINE",
  "slug": "foundation-medicine",
  "state": "MA",
  "description": "Molecular insight company, connects physicians & patients to the latest cancer treatment",
  "totalSpending": 1710000,
  "filings": 22,
  "yearlySpending": [
    {
      "year": 2020,
      "income": 190000
    },
    {
      "year": 2021,
      "income": 400000
    },
    {
      "year": 2022,
      "income": 400000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 160000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH",
    "PETER FISE",
    "LAURA FRIEDEL",
    "PARICK CARROLL"
  ],
  "issues": [
    "HCR",
    "BUD",
    "MMM",
    null,
    "TRD"
  ],
  "sampleDescriptions": [
    "Companion diagnostics, genomics testing, cancer therapies, FDA user fee reauthorization",
    "companion diagnostics\nH.R. 6800 - The Heroes Act",
    "companion diagnostics",
    "companion diagnostics\nH.R. 6800 - The Heroes Act\nH.R. 133 - Consolidated Appropriations Act, 2021\ntesting",
    "companion diagnostics\nH.R. 133 - Consolidated Appropriations Act, 2021",
    "companion diagnostics\npayment issues\nH.R. 1319, American Rescue Pan of 2021",
    "companion diagnostics\ntesting\ninnovation\nsurprise billing implementation\nH.R. 1319, American Rescue Plan of 2021",
    "companion diagnostics\ntesting\ninnovation\nsurprise billing implementation\nH.R. 1319, American Rescue Plan of 2021 implementation",
    "companion diagnostics\npayment issues\nH.R. 1319, American Rescue Plan of 2021 implementation",
    "companion diagnostics\ntesting\ninnovation\nsurprise billing implementation\nH.R. 1319, American Rescue Plan of 2021 implementation\nH.R. 3, The Lower Drug Costs Now Act",
    "companion diagnostics\ntesting\ninnovation\nsurprise billing implementation\nH.R. 1319, American Rescue Plan of 2021 implementation\nH.R. 5376, the Build Back Better Act",
    "companion diagnostics, testing, innovation, surprise billing implementation H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID)",
    "companion diagnostics, payment issues",
    "H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation",
    "H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation",
    "H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation",
    "LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening",
    "Federal budget issues",
    "supply chain"
  ],
  "years": [
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": -16,
  "trajectory": "stable",
  "yearsActive": 6,
  "avgAnnualSpending": 285000,
  "peakYear": 2021,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 4
}